Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_assertion description "[MAL methylation status may therefore serve as a marker of platinum sensitivity while MAL protein may be a target for development of novel therapies aimed at enhancing sensitivity to platinum-based drugs in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_assertion evidence source_evidence_literature NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_assertion SIO_000772 19642140 NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_assertion wasDerivedFrom befree-2016 NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_assertion wasGeneratedBy ECO_0000203 NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.
- befree-2016 importedOn "2016-02-19" NP754396.RAzOEoEYF18BpN7pjOFF0VNTfqQwVeY1QBhRDRtUFJXQ8130_provenance.